Genzyme, Genzyme Transgenics deal

GENZ will fund GZTC's antithrombin III (ATIII) program through March 1997. GENZ will provide GZTC with a $10 million convertible line of credit and clinical trial support for ATIII in return for worldwide co-marketing rights, excluding Asia. GZTC produces ATIII in the milk of transgenic goats. ...